AI Assistant
Blog
Pricing
Log In
Sign Up
242 PARP-inhibitors beyond progression: a new way to manage oligometastatic ovarian cancer recurrence
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
